Jingya Xu

Angelica sinensis polysaccharide nanoparticles as a targeted drug delivery system for enhanced therapy of liver cancer

Yu Zhang, Zheng Cui, Hao Mei et al. · Carbohydrate Polymers · 2019 · 106 citations

Nanomedicine, Drug Targeting, Engineering +11

Self-assembled Angelica sinensis polysaccharide nanoparticles with an instinctive liver-targeting ability as a drug carrier for acute alcoholic liver damage protection

Kaiping Wang, Jingya Xu, Yan Liu et al. · International Journal of Pharmaceutics · 2020 · 57 citations

Nanomedicine, Instinctive Liver-targeting Ability, Hepatology +11

Correction of Anemia in Chronic Kidney Disease With Angelica sinensis Polysaccharide via Restoring EPO Production and Improving Iron Availability

Kaiping Wang, Jun Wu, Jingya Xu et al. · Frontiers in Pharmacology · 2018 · 47 citations · Full text

A multifunctional magnetic nanosystem based on “two strikes” effect for synergistic anticancer therapy in triple-negative breast cancer

Yu Zhang, Huiping Hu, Wen‐Qi Tang et al. · Journal of Controlled Release · 2020 · 41 citations

Nanoparticles, Nanomedicine, Magnetism +13

New understanding of Angelica sinensis polysaccharide improving fatty liver: The dual inhibition of lipid synthesis and CD36-mediated lipid uptake and the regulation of alcohol metabolism

Zihao He, Tingting Guo, Zheng Cui et al. · International Journal of Biological Macromolecules · 2022 · 32 citations

Metabolic Syndrome, Hepatology, Biochemistry +13